SPD-473 citrate is an inhibitior of serotonin/dopamine/norepinephrine reuptake.

SPD-473 inhibits the synaptic reuptake of dopamine, serotonin and noradrenaline, This makes it a potential triple reuptake inhibitor and can be used to treat Parkinson's disease.

161190-26-7

C23H31Cl2NO8S

552.47

SPD-473 citrate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years